Rivaroxaban - A safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases

Reumatologia

Volumn 54, Issue 3, 2016, Pages 146-149

  Haładyj, Ewa ^a   Olesińska, Marzena ^a  

^a NATIONAL INSTITUTE OF GERIATRICS   (Poland)

Author keywords

Antiphospholipid syndrome; Rivaroxaban; Thrombosis; Warfarin

Indexed keywords

ANTIVITAMIN K; CARDIOLIPIN ANTIBODY; ENOXAPARIN; HYDROXYCHLOROQUINE; RIVAROXABAN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL EXAMINATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LUNG EMBOLISM; MEDICAL HISTORY; PATIENT PREFERENCE; RECURRENT DISEASE; SPLENIC VEIN; SPLENIC VEIN THROMBOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VEIN THROMBOSIS;

EID: 84979272518     PISSN: 00346233     EISSN: None     Source Type: Journal    
DOI: 10.5114/reum.2016.61217     Document Type: Article

References (8)

1. Della Valle P, Crippa L, Safa O, et al Potential failure of the International Normalized Ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann Med Interne 1996; 147 (SUPPL. 1): 10-14.
2. Chighizola CB, Moia M, Meroni PL New oral anticoagulants in thrombotic antiphospholipid syndrome. Lupus 2014; 23: 1279-1282.
3. Erkan D, Aguiar CL, Andrade D, et al 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev 2014; 13: 685-696.
4. Cohen H, Machin SJ Antithrombotic treatment failures in anti-phospholipid syndrome: the new anticoagulants? Lupus 2010; 19: 486-491.
5. Signorelli F, Nogueira F, Domingues V, et al Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases. Clin Rheumatol 2016; 35: 801-805.
6. Bauersachs R, Berkowitz SD, Brenner B, et al Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499-2510.
7. The EINSTEIN-PE Investigators. Büller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366: 1287-1297.
8. Connolly SJ, Ezekowitz MD, Yusuf S, et al RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.